Your browser doesn't support javascript.
Should Remdesivir Be Used for the Treatment of Patients With COVID-19? Rapid, Living Practice Points From the American College of Physicians (Version 2, Update Alert 3).
Qaseem, Amir; Yost, Jennifer; Etxeandia-Ikobaltzeta, Itziar; Abraham, George M; Jokela, Janet A; Forciea, Mary Ann; Miller, Matthew C; Humphrey, Linda L.
  • Qaseem A; American College of Physicians, Philadelphia, Pennsylvania.
  • Yost J; American College of Physicians, Philadelphia, Pennsylvania, and Villanova University, Villanova, Pennsylvania.
  • Etxeandia-Ikobaltzeta I; American College of Physicians, Philadelphia, Pennsylvania.
  • Abraham GM; University of Massachusetts Medical School and Saint Vincent Hospital, Worcester, Massachusetts.
  • Jokela JA; University of Illinois College of Medicine at Urbana-Champaign, Champaign, Illinois.
  • Forciea MA; Penn Medicine, Philadelphia, Pennsylvania.
  • Miller MC; Penn Medicine, Philadelphia, Pennsylvania.
  • Humphrey LL; Portland Veterans Affairs Medical Center and Oregon Health & Science University, Portland, Oregon.
Ann Intern Med ; 175(5): W55-W57, 2022 05.
Article in English | MEDLINE | ID: covidwho-1939365
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Physicians / COVID-19 Drug Treatment Limits: Humans Language: English Journal: Ann Intern Med Year: 2022 Document Type: Article

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Physicians / COVID-19 Drug Treatment Limits: Humans Language: English Journal: Ann Intern Med Year: 2022 Document Type: Article